During the past decade, Pharmakologisches Studienzentrum Chemnitz GmbH conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pharmakologisches Studienzentrum Chemnitz GmbH" #1 sponsor was "Kowa Research Europe" with 4 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Emalex Biosciences Inc." with 2 trials sponsored and "Institut de Recherches Internationales Servier" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pharmakologisches Studienzentrum Chemnitz GmbH" #1 collaborator was "IQVIA Biotech" with 1 trials as a collaborator and "Precision For Medicine" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Pharmakologisches Studienzentrum Chemnitz GmbH" are "Alzheimer's Disease" (4 trials), "Dyslipidemia" (4 trials), "Depressive Disorder, Major" (2 trials), "Type II Diabetes Mellitus" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Pharmakologisches Studienzentrum Chemnitz GmbH" in a lesser frequency.

Most popular intervention types in "Pharmakologisches Studienzentrum Chemnitz GmbH" are "Drug" (17 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Pitavastatin" (4 trials), "Atorvastatin" (3 trials), "Ecopipam" (2 trials) and "Gantenerumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pharmakologisches Studienzentrum Chemnitz GmbH" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Pharmakologisches Studienzentrum Chemnitz GmbH". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Pharmakologisches Studienzentrum Chemnitz GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pharmakologisches Studienzentrum Chemnitz GmbH, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".